$DARA Headlines Dara chemo side-effect drug gets

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$DARA Headlines

Dara chemo side-effect drug gets 'orphan status' 10:16 a.m. Feb. 25, 2014 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 5:46 p.m. Dec. 29, 2010 - Kate Gibson

DARA Snags Second Orphan Indication For KRN5500 10:48 p.m. June 17, 2014 - Seeking Alpha
Dara compound named an orphan drug for myeloma 11:34 a.m. June 16, 2014 - Seeking Alpha
Why DARA BioSciences (DARA) Stock is Surging Today 10:55 a.m. June 16, 2014 - TheStreet.com
Why DARA Biosciences (DARA) Stock Is Plunging Today 10:30 a.m. May 30, 2014 - TheStreet.com
DARA Biosciences (DARA) Stock Plunges After Wednesday Surge 12:14 p.m. May 29, 2014 - TheStreet.com
Dara Biosciences (DARA) Stock Explodes Today (Update) 4:08 p.m. May 28, 2014 - TheStreet.com
Dara up big 1:45 p.m. May 28, 2014 - Seeking Alpha
DARA Bio - Waiting For Progress 11:55 a.m. May 14, 2014 - Seeking Alpha
10-Q: DARA BIOSCIENCES, INC. 4:27 p.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
CAPTURE Data Should Help Drive Soltamox Sales At DARA Bio 9:08 a.m. March 15, 2014 - Seeking Alpha
Tamoxifen tablet survey a mixed bag for Dara 8:54 a.m. March 13, 2014 - Seeking Alpha
More on DARA Bioscience 9:53 a.m. March 5, 2014 - Seeking Alpha
DARA up 10% premarket on Soltamox entry at Wellcare 9:53 a.m. March 5, 2014 - Seeking Alpha
SA PRO: Top Long And Short Ideas, Thursday February 27 8:30 a.m. Feb. 28, 2014 - Seeking Alpha
DARA: Next Steps After Awarding Of Orphan Designation For KRN5500 9:52 a.m. Feb. 27, 2014 - Seeking Alpha
Still Betting On DARA Bio 10:00 a.m. Feb. 11, 2014 - Seeking Alpha
10-K: DARA BIOSCIENCES, INC. 8:03 a.m. Feb. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notes From One-On-One Meetings During San Fran Biotech Week - Day 2 10:05 a.m. Jan. 23, 2014 - Seeking Alpha
Orphan Designation A Game-Changer For DARA 11:00 a.m. Dec. 16, 2013 - Seeking Alpha
10-Q: DARA BIOSCIENCES, INC. 5:36 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)


Agreements, Orphan Drug Designations, and Management Changes - Analyst Notes on Medtronic, DARA BioSciences, Sequenom, AcelRx and Pernix 5:20 a.m. June 19, 2014 - PR Newswire - PRF
DARA BioSciences Announces Leadership Transition 2:35 a.m. June 18, 2014 - Marketwire
DARA BioSciences' KRN5500 Granted Orphan Drug Designation by FDA for Treatment of Multiple Myeloma 7:01 a.m. June 16, 2014 - Marketwire
DARA BioSciences Launches Oral Mucositis Care App to Provide Cancer Patients with an Educational Resource to Improve Side Effect Management 8:02 a.m. June 3, 2014 - BusinessWire - BZX
Active Equities to Watch -- Research on CSX Corp., Gerdau, Walter Energy, and DARA BioSciences 8:00 a.m. June 2, 2014 - PR Newswire - PRF
DARA BioSciences, Inc. Announces Pricing of $12.5 Million Public Offering 8:48 a.m. May 30, 2014 - Marketwire
DARA BioSciences Observes National Neuropathy Awareness Week 8:32 a.m. May 15, 2014 - Marketwire
DARA BioSciences Announces First Quarter 2014 Results 4:11 p.m. May 12, 2014 - Marketwire
DARA BioSciences Announces New Retail Patient Savings Program to Support Market Demand for DARA's Flagship Oncology Products 8:31 a.m. May 9, 2014 - Marketwire
DARA BioSciences Announces Addition of Soltamox(R), (Tamoxifen Citrate) Oral Solution, to the Authorized Federal Supply Schedule Price List 8:04 a.m. May 8, 2014 - Marketwire
DARA BioSciences Announces Date and Time for Announcement of First Quarter 2014 Results 1:14 p.m. April 30, 2014 - Marketwire
Dara BioSciences to Present at the 12th Annual eyeforpharma Philadelphia 2014 Summit 8:06 a.m. April 14, 2014 - Marketwire
DARA BioSciences Presents Results of Breast Cancer CAPTURE Registry at NCCN® 19th Annual Conference: Advancing the Standard of Cancer Care™ 8:01 a.m. March 13, 2014 - BusinessWire - BZX
DARA BioSciences to Present at 26th Annual ROTH Conference 9:06 a.m. March 6, 2014 - Marketwire
DARA BioSciences Signs Medicare Part D Prescription Drug Agreement With the WellCare(R) Group, Providing Approved Formulary Status for Soltamox(R) 9:06 a.m. March 5, 2014 - Marketwire
DARA BioSciences Observes Rare Disease Day 9:36 a.m. Feb. 27, 2014 - Marketwire
DARA BioSciences Regains Compliance With NASDAQ Bid Price Requirement 5:02 p.m. Feb. 25, 2014 - Marketwire
DARA BioSciences' KRN5500 Receives Orphan Drug Designation From FDA 9:06 a.m. Feb. 25, 2014 - Marketwire
DARA BioSciences Announces Registered Direct Offering of $6.0 Million 9:31 a.m. Feb. 12, 2014 - Marketwire
DARA BioSciences Announces 1-for-5 Reverse Split 9:02 a.m. Feb. 6, 2014 - Marketwire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 6

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

Comprehensive Overview of Marlowe PLC's Latest Disclosure

Updated Category News Views 133

Understanding the Disclosure from Marlowe PLC The public opening position disclosure from Marlowe PLC brings vital information to investors and stakeholders. It serves as an essential document under the rules established by the Takeover Code. A disclosure like this outlines the interests stakeholders hold in relevant securities, especially when they represent 1% or...

Continue Reading
Harvard Extension School's Social Media Triumph at UPCEA

Updated Category News Views 210

Harvard Extension School's #HESProud Campaign Achievements The Harvard Extension School (HES) proudly announces its victory with the #HESProud social media campaign, honored as the GOLD recipient of the UPCEA's Excellence in Marketing Award for 2024. This notable accolade it received celebrates the campaign's creativity and engagement, which resonated significantly across...

Continue Reading
AI in CX: The Gap Between Hype and Reality

Updated Category News Views 5

AI in Customer Experience: Not Quite There Yet Let's dive into what TELUS Digital and Ryan Strategic Advisory's survey reveals: enterprises are tossing AI into their customer experience (CX) operations like confetti, yet they're fumbling when it comes to actually tracking if it’s doing any good. Most are relying on human agents propped up by AI, with a solid 61% rolling...

Continue Reading
Humana and Longevity Health Team Up to Boost Medicare Access

Updated Category News Views 108

Humana and Longevity Health Join Forces for Expanded Access In an important alliance, Humana Inc. (NYSE: HUM) and Longevity Health have unveiled a multi-state initiative set to enhance accessibility to Humana Together in Health, which is a Medicare Advantage Institutional Special Needs Plan (I-SNP). This collaboration focuses on providing personalized care to individuals...

Continue Reading
Key Ruling in Niger Delta Oil Pollution Issue by High Court

Updated Category News Views 299

Groundbreaking Judgment in Niger Delta Oil Pollution Case In a significant ruling, the English High Court addressed ongoing litigation regarding oil pollution in the Niger Delta, focusing specifically on the Bille and Ogale regions. This decision, delivered by Justice May, aims to clarify complex legal issues and streamline the upcoming trial process. Facing off in this...

Continue Reading